Muscle Pharm Corporation (MSLPQ)

[Art Vandeley]

Filed today, page 12

Common stock underlying Series D preferred stock in this offering 3,000,000 shares of common stock.
Common stock to be outstanding after this offering assuming full conversion of Series
D preferred stock
5,974,135 shares of common stock.
Use of proceeds We intend to use the net proceeds received from this offering to retire a bridge loan of $1.0
million and $3.5 million of debt due on completion of this offering and for working capital and
general corporate purposes.

http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=8984797